SE436874B - N-substituerade moranolinderivat - Google Patents

N-substituerade moranolinderivat

Info

Publication number
SE436874B
SE436874B SE7903817A SE7903817A SE436874B SE 436874 B SE436874 B SE 436874B SE 7903817 A SE7903817 A SE 7903817A SE 7903817 A SE7903817 A SE 7903817A SE 436874 B SE436874 B SE 436874B
Authority
SE
Sweden
Prior art keywords
water
substituted
moranoline derivatives
derivatives
substituted moranoline
Prior art date
Application number
SE7903817A
Other languages
English (en)
Swedish (sv)
Other versions
SE7903817L (sv
Inventor
S Matsumura
H Enomoto
Y Aoyagi
Y Yoshikuni
K Kura
M Yagi
I Shirahase
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53053603A external-priority patent/JPS5943947B2/ja
Priority claimed from JP8260678A external-priority patent/JPS5943948B2/ja
Priority claimed from JP12066178A external-priority patent/JPS5943949B2/ja
Priority claimed from JP571479A external-priority patent/JPS6026387B2/ja
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of SE7903817L publication Critical patent/SE7903817L/xx
Publication of SE436874B publication Critical patent/SE436874B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7903817A 1978-05-03 1979-05-02 N-substituerade moranolinderivat SE436874B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP53053603A JPS5943947B2 (ja) 1978-05-03 1978-05-03 Ｎ−置換モラノリン誘導体
JP8260678A JPS5943948B2 (ja) 1978-07-06 1978-07-06 置換モラノリン誘導体
JP12066178A JPS5943949B2 (ja) 1978-09-29 1978-09-29 モラノリンのｎ−置換誘導体
JP571479A JPS6026387B2 (ja) 1979-01-20 1979-01-20 シンナミルモラノリン誘導体

Publications (2)

Publication Number Publication Date
SE7903817L SE7903817L (sv) 1979-11-04
SE436874B true SE436874B (sv) 1985-01-28

Family

ID=27454348

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7903817A SE436874B (sv) 1978-05-03 1979-05-02 N-substituerade moranolinderivat
SE8402550A SE451016B (sv) 1978-05-03 1984-05-11 N-substituerade derivat av moranolin
SE8402549A SE451015B (sv) 1978-05-03 1984-05-11 Substituerade moranolinderivat
SE8402551A SE451017B (sv) 1978-05-03 1984-05-11 Cinnamylmoranolin-derivat

Family Applications After (3)

Application Number Title Priority Date Filing Date
SE8402550A SE451016B (sv) 1978-05-03 1984-05-11 N-substituerade derivat av moranolin
SE8402549A SE451015B (sv) 1978-05-03 1984-05-11 Substituerade moranolinderivat
SE8402551A SE451017B (sv) 1978-05-03 1984-05-11 Cinnamylmoranolin-derivat

Country Status (9)

Country Link
US (1) US4533668A (de)
CH (1) CH642629A5 (de)
DE (1) DE2915037C3 (de)
DK (1) DK151623C (de)
FR (1) FR2424910A1 (de)
GB (1) GB2020278B (de)
IT (1) IT1116820B (de)
NL (1) NL175820C (de)
SE (4) SE436874B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2925943A1 (de) * 1979-06-27 1981-01-29 Bayer Ag 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2942365A1 (de) * 1979-10-19 1981-05-14 Bayer Ag, 5090 Leverkusen 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
JP2504000B2 (ja) * 1986-09-02 1996-06-05 日本新薬株式会社 グルコシルモラノリン誘導体
JPS6461459A (en) * 1987-08-28 1989-03-08 Nippon Shinyaku Co Ltd Moranoline derivative
GB8827701D0 (en) * 1987-12-09 1988-12-29 Nippon Shinyaku Co Ltd Thrombolytic &c compositions
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
US4985445A (en) * 1988-02-12 1991-01-15 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitors and novel compounds
EP0350012A3 (de) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antivirale Zusammensetzung
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
ES2095032T3 (es) * 1992-04-01 1997-02-01 Searle & Co Derivados 2- y 3-amino y azido de 1,5-iminoazucares como compuestos antivirales.
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
US5798366A (en) * 1993-05-13 1998-08-25 Monsanto Company Method for treatment of CNS-involved lysosomal storage diseases
US6291657B1 (en) 1993-05-13 2001-09-18 Monsanto Company Deoxygalactonojirimycin derivatives
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
MY122499A (en) 1997-11-10 2006-04-29 Searle & Co Use of alkylated iminosugars to treat multidrug resistance
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
BR9907882A (pt) 1998-02-12 2000-10-17 Searle & Co Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite
WO2001008672A2 (en) 1999-02-12 2001-02-08 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
US6545021B1 (en) 1999-02-12 2003-04-08 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
CN1422156A (zh) * 2000-02-14 2003-06-04 法马西亚公司 N－取代的－1,5－二脱氧－1,5－亚氨基－d－葡萄糖醇化合物在治疗肝炎病毒感染中的用途
US8003617B2 (en) * 2004-11-10 2011-08-23 Genzyme Corporation Methods of treating diabetes mellitus
AT502145B1 (de) * 2005-03-24 2012-01-15 Univ Graz Tech Glycosidase-hemmendes iminoalditol
PT2032134E (pt) 2006-05-09 2015-10-07 Genzyme Corp Métodos de tratamento da doença do fígado gorduroso
CN104876855A (zh) * 2006-05-24 2015-09-02 联合治疗公司 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
EP2594565B1 (de) * 2007-05-31 2018-10-24 Genzyme Corporation Glukosylceramid-Synthase-Hemmer vom 2-Acylaminpropanol-Typ
EP2209473B1 (de) 2007-10-05 2017-11-22 Genzyme Corporation Verfahren zur behandlung von polyzystischer nierenerkrankung mit ceramid-derivaten
US8389517B2 (en) 2008-07-28 2013-03-05 Genzyme Corporation Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
MX2011003517A (es) 2008-10-03 2011-05-25 Genzyme Corp Inhibidores de la glucosilceramida sintasa tipo 2-acilaminopropanol.
WO2017192599A1 (en) 2016-05-02 2017-11-09 Florida State University Research Foundation, Inc. Treatment of zika virus infections using alpha-glucosidase inhibitors
EP4106752A4 (de) 2020-02-21 2024-03-20 Florida State University Research Foundation, Inc. Behandlung von infektionen mit dem humanen coronavirus unter verwendung von alpha-glucosidase-glykoprotein-prozessierungsinhibitoren
US20230174486A1 (en) * 2020-05-07 2023-06-08 ALECTOS THERAPEUTICS lNC. Non-lysosomal glucosylceramidase inhibitors and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5282710A (en) * 1975-12-29 1977-07-11 Nippon Shinyaku Co Ltd Extraction of effective drug component from mulberry
DE2735316C3 (de) * 1977-08-05 1981-01-29 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von nadeiförmigen, ferrimagnetischen Eisenoxiden

Also Published As

Publication number Publication date
SE8402549D0 (sv) 1984-05-11
NL7903421A (nl) 1979-11-06
FR2424910A1 (fr) 1979-11-30
IT7948904A0 (it) 1979-05-02
DE2915037C3 (de) 1981-11-05
SE8402549L (sv) 1984-05-11
GB2020278B (en) 1983-02-23
DK151623C (da) 1988-07-18
SE8402551L (sv) 1984-05-11
DK151623B (da) 1987-12-21
DK178379A (da) 1979-11-04
SE451017B (sv) 1987-08-24
FR2424910B1 (de) 1981-12-11
SE451016B (sv) 1987-08-24
GB2020278A (en) 1979-11-14
DE2915037A1 (de) 1979-11-08
DE2915037B2 (de) 1981-01-29
NL175820B (nl) 1984-08-01
SE8402550D0 (sv) 1984-05-11
CH642629A5 (de) 1984-04-30
IT1116820B (it) 1986-02-10
US4533668A (en) 1985-08-06
SE451015B (sv) 1987-08-24
SE8402551D0 (sv) 1984-05-11
SE7903817L (sv) 1979-11-04
SE8402550L (sv) 1984-05-11
NL175820C (nl) 1985-01-02

Similar Documents

Publication Publication Date Title
SE436874B (sv) N-substituerade moranolinderivat
KR100908796B1 (ko) 아세트산아닐리드 유도체의 α형 또는 β형 결정
EP0148725B1 (de) Sulfonamido-Benzamid-Derivate
EP3280417B1 (de) Xanthin-substituierte alkynylcarbamate/reverse carbamate als a2b-antagonisten
US4366166A (en) Filaricidal 2-nitroimidazole compounds
HU203548B (en) Process for producing benzoxazine derivatives and pharmaceutical compositions containing them
JPS6312063B2 (de)
JPS5845423B2 (ja) 新規アミノプロパノ−ル・誘導体の製法
RU2228931C2 (ru) Кристаллические формы 3-(2,4-дихлорбензил)-2-метил-n-(пентилсульфонил)-3h- бензимидазол-5-карбоксамида
US3030371A (en) Process for the preparation of d-and l-aryl-(2-pyridyl)-amino alkanes
US3317545A (en) [2-(2, 6-dimethylpiperidino)ethyl]guanidines and intermediates
US4402981A (en) N1 -Acyl-N2 -phenyl-diaminopropanols and pharmaceutical compositions thereof and processes for their preparation
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
SE420311B (sv) N-alkenyl-2-hydroximetyl-3,4,5-trihydroxipiperidin
KR820001123B1 (ko) N-치환 몰라노린 유도체의 제조방법
US3939172A (en) 4-Aminothiazole
JPS5943947B2 (ja) Ｎ−置換モラノリン誘導体
US3226379A (en) Novel 1,3-bis(polyhydroxyalkyl)-2-imidazolidinones and 1,3-bis(polyhydroxyalkyl)-imidazolidine-2-thiones
JPS6026387B2 (ja) シンナミルモラノリン誘導体
US3152123A (en) Process for the preparation of benzo-
EP0001266B1 (de) Substituierte 2-Aminomethylphenyl Sulfamate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
CS208746B2 (en) Method of making the 3,6-disubstituted-1,2,4-triazin 5-ons
US20040157821A1 (en) Sulfate of cephem compound
CA1232614A (en) Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl) -2-methylalanine esters and process
NO152436B (no) Haarfargemiddel

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7903817-0

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7903817-0

Format of ref document f/p: F